Fellow in Interventional Cardiology at Duke University, School of Medicine
As of 2025 · Last known relationship
Dennis Narcisse is a Duke cardiologist and Assistant Professor of Medicine whose work connects interventional cardiology with clinical research on antiplatelet therapy, peripheral artery disease, health disparities, and pragmatic trial follow-up. He completed an M.S. at Mississippi College in 2012 and an M.D. at the University of Tennessee Health Science Center in 2017, followed by Duke internal medicine residency from 2017 to 2020. He served as a cardiology fellow in 2020-2021 and 2022-2024, chief resident in internal medicine in 2021-2022, a cardiology research fellow in 2023-2024, and an interventional cardiology fellow in 2024-2025. His publications include studies of cangrelor, aspirin dosing, PAD, frailty, and early-career interventional cardiology. He has also taught clinicians about venous thromboembolism and antithrombotic bleeding risk.
Each topic is linked to its supporting source in Sources.
Training includes Fellow in Interventional Cardiology at Duke University, School of Medicine, Research Fellow in Cardiology at Duke University, School of Medicine, Cardiology Fellow at Duke University, School of Medicine, and Presented on bleeding in patients with atrial fibrillation and acute coronary syndrome or PCI treated with antithrombotic therapy at TCT 2022, plus 7 more records.
Explore education and trainingAs of 2025
As of 2024
As of 2024
2024
As of 2022
As of 2022
As of 2021
As of 2020
As of 2012
Completed 2017
Author of an American College of Cardiology Expert Analysis on aspirin dose for secondary prevention[12]
2021
Publication: A Delicate Matter: The Burden of Frailty on AMI-CS[9]
2024
Publication: Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trial[9]
2025
Publication: Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States[9]
2024
Publication: Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study[9]
2024
Publication: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial[9]
2024
Publication: Impact of risk factor control on peripheral artery disease outcomes and health disparities[9]
2022
Publication: Reply: Early-Career Interventionalists: Hope for the Future and Opportunity for Change[9]
2024
Publication: The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO Registry[9]
2024
Publication: Treatment considerations in patients with combined carotid and coronary artery disease[9]
2025
Publication: Use of Cangrelor for Patients Undergoing Coronary Artery Bypass Grafting: Insights From the CAMEO Registry[9]
2025